Related references
Note: Only part of the references are listed.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Advances in siRNA delivery strategies for the treatment of MDR cancer
Md Abdus Subhan et al.
LIFE SCIENCES (2021)
Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy
Milad Ashrafizadeh et al.
CARBOHYDRATE POLYMERS (2021)
Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
Sepideh Mirzaei et al.
LIFE SCIENCES (2021)
Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy
Sepideh Mirzaei et al.
LIFE SCIENCES (2021)
A supramolecular co-delivery strategy for combined breast cancer treatment and metastasis prevention
Yuxuan Chen et al.
CHINESE CHEMICAL LETTERS (2020)
Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
Liuwan Zhao et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells
Alessandra Affinito et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Metastasis-initiating cells induce and exploit a fibroblast niche to fuel malignant colonization of the lungs
Maren Pein et al.
NATURE COMMUNICATIONS (2020)
Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal tracking
George D. Cresswell et al.
NATURE COMMUNICATIONS (2020)
Monoclonal Antibody 2C5-Modified Mixed Dendrimer Micelles for Tumor-Targeted Codelivery of Chemotherapeutics and siRNA
Jiayi Pan et al.
MOLECULAR PHARMACEUTICS (2020)
Systemic Delivery of Aptamer-Conjugated XBP1 siRNA Nanoparticles for Efficient Suppression of HER2+Breast Cancer
Long Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Exosomes as drug delivery systems: A brief overview and progress update
Suyash M. Patil et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
siRNA based drug design, quality, delivery and clinical translation
Md Abdus Subhan et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Juliane Winkler et al.
NATURE COMMUNICATIONS (2020)
Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy
Milad Ashrafizadeh et al.
ACS COMBINATORIAL SCIENCE (2020)
A Review of Biodegradable Natural Polymer-Based Nanoparticles for Drug Delivery Applications
Humaira Idrees et al.
NANOMATERIALS (2020)
Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements
Dima Hattab et al.
PHARMACEUTICS (2020)
Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer
Milad Ashrafizadeh et al.
BIOENGINEERING-BASEL (2020)
A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis
Xukun Li et al.
THERANOSTICS (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy
Amita M. Vaidya et al.
BIOCONJUGATE CHEMISTRY (2019)
PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms
Xuan Jiang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Hydrogels and Their Applications in Targeted Drug Delivery
Radhika Narayanaswamy et al.
MOLECULES (2019)
MEDICAL RESEARCH Molecular envoys aid cancer spread
Anirban Maitra
NATURE (2019)
Strategies, design, and chemistry in siRNA delivery systems
Yizhou Dong et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Efficient nanocarriers of siRNA therapeutics for cancer treatment
Md Abdus Subhan et al.
TRANSLATIONAL RESEARCH (2019)
MetaGxData: Clinically Annotated Breast, Ovarian and Pancreatic Cancer Datasets and their Use in Generating a Multi-Cancer Gene Signature
Deena M. A. Gendoo et al.
SCIENTIFIC REPORTS (2019)
Nanoparticle-siRNA: a potential strategy for ovarian cancer therapy?
Shahin Aghamiri et al.
NANOMEDICINE (2019)
EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer
Elif Asik et al.
NANOMEDICINE (2019)
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
Kha-Liang Lee et al.
CANCERS (2019)
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge
Milica Nedeljkovic et al.
CELLS (2019)
Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives
Alka Singh et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
BRCA1 Deficiency Upregulates NNMT, Which Reprograms Metabolism and Sensitizes Ovarian Cancer Cells to Mitochondrial Metabolic Targeting Agents
Arun Kanakkanthara et al.
CANCER RESEARCH (2019)
Strategies for Delivery of siRNAs to Ovarian Cancer Cells
Rossella Farra et al.
PHARMACEUTICS (2019)
Ovarian metastasis from breast cancer: a comprehensive review
W. Tian et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
Takeshi Motohara et al.
ONCOGENE (2019)
Development of a Biocompatible Copolymer Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer
Zhen Zhao et al.
THERANOSTICS (2019)
Surface-engineered polyethyleneimine-modified liposomes as novel carrier of siRNA and chemotherapeutics for combination treatment of drug-resistant cancers
Livia P. Mendes et al.
DRUG DELIVERY (2019)
p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts
Kathryn A. Mills et al.
SCIENTIFIC REPORTS (2019)
Ovarian Metastases of Breast Cancers With Signet Ring Cells: A Report of 17 Cases Including 14 Krukenberg Tumors
Jennifer A. Bennett et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2018)
Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells
Manoj B. Parmar et al.
ACTA BIOMATERIALIA (2018)
Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
Ga Hee Kim et al.
DRUG DELIVERY (2018)
siRNA in ovarian cancer - Delivery strategies and targets for therapy
Dirk van den Brand et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Blocking Sternness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70S6K with Dendrimer Nanovector-Based siRNA Delivery
Jing Ma et al.
MOLECULAR THERAPY (2018)
Liposomal Drug Delivery Systems and Anticancer Drugs
Temidayo O. B. Olusanya et al.
MOLECULES (2018)
Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment
Shenda Gu et al.
PLOS ONE (2018)
Expression and clinical significance of survivin in ovarian cancer: A meta-analysis
Xiaoyan He et al.
PLOS ONE (2018)
Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design
Anne Marit de Groot et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Metastatic and triple-negative breast cancer: challenges and treatment options
Sumayah Al-Mahmood et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
Periostin: A Matricellular Protein with Multiple Functions in Cancer Development and Progression
Laura Gonzalez-Gonzalez et al.
FRONTIERS IN ONCOLOGY (2018)
PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy
Jinju Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy
Susan E. Logue et al.
NATURE COMMUNICATIONS (2018)
TRPC6 Channels Are Required for Proliferation, Migration and Invasion of Breast Cancer Cell Lines by Modulation of Orai1 and Orai3 Surface Exposure
Isaac Jardin et al.
CANCERS (2018)
Recent advancements in the use of exosomes as drug delivery systems
Edwin J. Bunggulawa et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
Effective Therapy Using a Liposomal siRNA that Targets the Tumor Vasculature in a Model Murine Breast Cancer with Lung Metastasis
Yu Sakurai et al.
MOLECULAR THERAPY-ONCOLYTICS (2018)
Current knowledge on exosome biogenesis and release
Nina Pettersen Hessvik et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis
Xinyan Chen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies
Abhirup Mandal et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform
Jingga Morry et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Livia Palmerston Mendes et al.
MOLECULES (2017)
Epidemiology of ovarian cancer: a review
Brett M. Reid et al.
CANCER BIOLOGY & MEDICINE (2017)
Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells
Marcello Monti et al.
PLOS ONE (2017)
Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer
Hyun Hee Lee et al.
PLOS ONE (2017)
Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing
Yuchen Wang et al.
BIOMATERIALS (2017)
The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review
Ondrej Kubecek et al.
CLINICAL & EXPERIMENTAL METASTASIS (2017)
Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs
Farnaz Fouladi et al.
BIOCONJUGATE CHEMISTRY (2017)
Cooperative Treatment of Metastatic Breast Cancer Using Host-Guest Nanoplatform Coloaded with Docetaxel and siRNA
Dangge Wang et al.
SMALL (2016)
Gold-nanorods-siRNA nanoplex for improved photothermal therapy by gene silencing
Bei-Ke Wang et al.
BIOMATERIALS (2016)
The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma
Vandana Sandhu et al.
CANCER RESEARCH (2016)
A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to Tumorigenesis
Mckenna Longacre et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs
Agata Jablonska-Trypuc et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis
Bilge Oeren et al.
JOURNAL OF PATHOLOGY (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Ovarian metastasis from non-small cell lung cancer with ALK and EGFR mutations: A report of two cases
Rosemary T. Mushi et al.
ONCOLOGY LETTERS (2016)
Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness
Alexandra Avgustinova et al.
NATURE COMMUNICATIONS (2016)
ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
Peng Guo et al.
THERANOSTICS (2016)
Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy
Lisa Y. Pang et al.
STEM CELLS INTERNATIONAL (2016)
The biology and function of fibroblasts in cancer
Raghu Kalluri
NATURE REVIEWS CANCER (2016)
Triple-Punch Strategy for Triple Negative Breast Cancer Therapy with Minimized Drug Dosage and Improved Antitumor Efficacy
Shishuai Su et al.
ACS NANO (2015)
Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer
Worapol Ngamcherdtrakul et al.
ADVANCED FUNCTIONAL MATERIALS (2015)
Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer
Jenny G. Parvani et al.
CANCER RESEARCH (2015)
Biomedical applications of hydrogels: A review of patents and commercial products
Enrica Calo et al.
EUROPEAN POLYMER JOURNAL (2015)
Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
George Mattheolabakis et al.
JOURNAL OF DRUG TARGETING (2015)
Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer
Giuseppina Salzano et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Synchronous Primary Carcinoma of Breast and Ovary Versus Ovarian Metastases
Budhi S. Yadav et al.
SEMINARS IN ONCOLOGY (2015)
MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
Xiaoqian Yang et al.
SCIENTIFIC REPORTS (2015)
RNA-Based TWIST1 Inhibition via Dendrimer Complex to Reduce Breast Cancer Cell Metastasis
James Finlay et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The emerging regulation of veGFR-2 in triple-negative breast cancer
Xiaoxia Zhu et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Lipidoid Nanoparticles for siRNA Delivery to the Intestinal Epithelium: In Vitro Investigations in a Caco-2 Model
Rebecca L. Ball et al.
PLOS ONE (2015)
Liposomal siRNA nanocarriers for cancer therapy
Bulent Ozpolat et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth
Takahiro Ochiya et al.
ANGIOGENESIS (2014)
Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: A promising strategy to overcome drug resistance in cancer
G. Salzano et al.
CANCER LETTERS (2014)
The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy
Ruth Scherz-Shouval et al.
CELL (2014)
Intercellular adhesion molecule-1 mediates murine colon adenocarcinoma invasion
Kenton Howard et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Inhibiting Metastatic Breast Cancer Cell Migration via the Synergy of Targeted, pH-triggered siRNA Delivery and Chemokine Axis Blockade
Peng Guo et al.
MOLECULAR PHARMACEUTICS (2014)
Pathological and prognostic significance of hypoxia-inducible factor 1α expression in epithelial ovarian cancer: a meta-analysis
Yue Jin et al.
TUMOR BIOLOGY (2014)
Polymeric micelles as drug delivery vehicles
Zaheer Ahmad et al.
RSC ADVANCES (2014)
Enhanced Intracellular siRNA Delivery using Bioreducible Lipid-Like Nanoparticles
Ming Wang et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Multifunctional Gold Nanorods for siRNA Gene Silencing and Photothermal Therapy
Jianliang Shen et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells
Samreen Khatri et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2014)
Layer-by-Layer Nanoparticles for Systemic Codelivery of an Anticancer Drug and siRNA for Potential Triple-Negative Breast Cancer Treatment
Zhou J. Deng et al.
ACS NANO (2013)
Preoperative clinical and radiological features of metastatic ovarian tumors
Ilan Bruchim et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2013)
Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug
Vatsal Shah et al.
CLINICAL CANCER RESEARCH (2013)
Autotransplantation of cryopreserved ovarian tissue in cancer survivors and the risk of reintroducing malignancy: a systematic review
L. Bastings et al.
HUMAN REPRODUCTION UPDATE (2013)
Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs
Ying Lu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Current trends in the use of liposomes for tumor targeting
Pranali P. Deshpande et al.
NANOMEDICINE (2013)
Lung cancer diagnosis on ovary mass: a case report
Nunzia Simona Losito et al.
JOURNAL OF OVARIAN RESEARCH (2013)
COX2 regulation of breast cancer bone metastasis
John Karavitis et al.
ONCOIMMUNOLOGY (2013)
Dendrimers for siRNA Delivery
Swati Biswas et al.
PHARMACEUTICALS (2013)
Refining the role of BRCA1 in combating oxidative stress
Jeffrey R. Marks
BREAST CANCER RESEARCH (2013)
Combinatorial Library of Lipidoids for In Vitro DNA Delivery
Shuo Sun et al.
BIOCONJUGATE CHEMISTRY (2012)
Breast cancer metastasising to the pelvis and abdomen: what the gynaecologist needs to know
E. K. Moore et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2012)
Risk of Metastatic Ovarian Involvement in Nongynecologic Malignancies
Kidong Kim et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
A Case of Pseudo-Meigs' Syndrome Associated with Ovarian Metastases from Breast Cancer
Koma Naito et al.
JOURNAL OF BREAST CANCER (2012)
Breast and Ovarian Cancers: A Survey and Possible Roles for the Cell Surface Heparan Sulfate Proteoglycans
Atsuko Yoneda et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2+ Breast Cancer Growth and Metastasis
Yan-dan Yao et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor
S. Guerriero et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2012)
S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells
Dong Chen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer
Mikkel Rosendahl et al.
FERTILITY AND STERILITY (2011)
Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from breast carcinoma in effusions
Ben Davidson et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
SiRNA delivery with exosome nanoparticles
Jasper G. van den Boorn et al.
NATURE BIOTECHNOLOGY (2011)
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
Dennis Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
TWIST1 Is Expressed in Colorectal Carcinomas and Predicts Patient Survival
Irene Gomez et al.
PLOS ONE (2011)
Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells
Michael S. Goldberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Delivery of siRNA Therapeutics: Barriers and Carriers
Jie Wang et al.
AAPS JOURNAL (2010)
Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
Neta Erez et al.
CANCER CELL (2010)
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Hee Dong Han et al.
CLINICAL CANCER RESEARCH (2010)
Lipid-like materials for low-dose, in vivo gene silencing
Kevin T. Love et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Liposomes as 'smart' pharmaceutical nanocarriers
Rupa R. Sawant et al.
SOFT MATTER (2010)
Pseudo-Meigs' syndrome associated with breast cancer metastasis to both ovaries: Report of a case
Naonori Kawakubo et al.
SURGERY TODAY (2010)
Polymers for Drug Delivery Systems
William B. Liechty et al.
ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 1 (2010)
Peptide-Functionalized Nanogels for Targeted siRNA Delivery
William H. Blackburn et al.
BIOCONJUGATE CHEMISTRY (2009)
Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA
M. Mikhaylova et al.
CANCER GENE THERAPY (2009)
Nanoparticle-based targeted drug delivery
Rajesh Singh et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
FAK overexpression and p53 mutations are highly correlated in human breast cancer
Vita M. Golubovskaya et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Secondary Ovarian Malignancies Frequency, Origin, and Characteristics
Yvonne R. P. de Waal et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Hsp90 Is an Essential Regulator of EphA2 Receptor Stability and Signaling: Implications for Cancer Cell Migration and Metastasis
Balasubramaniam Annamalai et al.
MOLECULAR CANCER RESEARCH (2009)
Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis
Yu-Hung Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Effect of hydrogel porosity on marrow stromal cell phenotypic expression
Mahrokh Dadsetan et al.
BIOMATERIALS (2008)
Phase II trial of cetuximab and carboplatin in relapsed platinum-sensitive ovarian cancer and evaluation of epidermal growth factor receptor expression: A Gynecologic Oncology Group study
Angeles Alvarez Secord et al.
GYNECOLOGIC ONCOLOGY (2008)
Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets
Claude Chelala et al.
BMC GENOMICS (2007)
Regulation of the CLDN3 gene in ovarian cancer cells
Hiroshi Honda et al.
CANCER BIOLOGY & THERAPY (2007)
From Krukenberg to today: The ever present problems posed by metastatic tumors in the ovary. Part II
Robert H. Young
ADVANCES IN ANATOMIC PATHOLOGY (2007)
Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells
Ioannis Stasinopoulos et al.
MOLECULAR CANCER RESEARCH (2007)
Role of BRCA1 and BRCA2 mutations in pancreatic cancer
Julia B. Greer et al.
GUT (2007)
Analysis of metastatic ovarian tumors from extragenital primary sites
Taner Turan et al.
TUMORI (2006)
Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31
E Tan-Chiu et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Abdominal carcinomatosis in women with a history of breast cancer
R Garg et al.
GYNECOLOGIC ONCOLOGY (2005)
BRCA1 in breast and ovarian cancer predisposition
B Billack et al.
CANCER LETTERS (2005)
Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity
R Agarwal et al.
CANCER RESEARCH (2005)
The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries
A Ayhan et al.
GYNECOLOGIC ONCOLOGY (2005)
Design and development of polymers for gene delivery
DW Pack et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Diagnostic challenge of secondary (metastatic) ovarian tumors simulating primary endometrioid and mucinous neoplasms
WR Hart
PATHOLOGY INTERNATIONAL (2005)
Ovarian malignancy in breast cancer patients with an adnexal mass
F Simpkins et al.
OBSTETRICS AND GYNECOLOGY (2005)
Prediction of cancer outcome with microarrays: a multiple random validation strategy
S Michiels et al.
LANCET (2005)
Ovarian metastasis originating from bronchioloalveolar carcinoma: a rare presentation of lung cancer
KY Yeh et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2003)
Breast cancer metastatic to abdomen and pelvis: role of surgical resection
R Eitan et al.
GYNECOLOGIC ONCOLOGY (2003)
Gene expression in cancer: the application of microarrays
PF Macgregor
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2003)
Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens
DC Chhieng et al.
CANCER CYTOPATHOLOGY (2001)
Share Paper
